UPMC

UPMC is one of the leading nonprofit health systems in the United States. A $500 billion integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, UPMC develops and delivers Life Changing Medicine by harnessing the power of technology, translating science into cures, and accelerating the pace of innovation worldwide.

Frederick M. Hargett

CFO

28 past transactions

Xealth

Series B in 2021
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

CarepathRx

Corporate Round in 2020
CarepathRx transforms hospital pharmacy from a cost center into an active revenue generator through a powerful combination of technology, market-leading pharmacy services and wrap-around services.

Abridge

Series A in 2020
Abridge is a healthcare technology company that uses generative AI to automate the transcription and summarization of medical discussions. The platform transforms patient-clinician conversations into structured clinical notes in real-time, integrating with Electronic Health Record (EHR) systems. It reduces the need for manual note-taking, enhances patient understanding by generating clear, understandable summaries, and ensures that documentation is added to patient records. Abridge prioritizes data security and patient privacy, complying with healthcare regulations while offering a customizable interface tailored to patient needs.

Prodigo Solutions

Venture Round in 2019
Prodigo Solution is a healthcare supply chain professional, is focused on driving real savings in the healthcare supply chain.

Werewolf Therapeutics

Series A in 2019
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

RxAnte

Funding Round in 2019
RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members while working with their prescribers and caregivers to make regimens safer, simpler, and more affordable.

Xealth

Series A in 2019
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

Health Catalyst

Series F in 2019
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

Prodigo Solutions

Venture Round in 2018
Prodigo Solution is a healthcare supply chain professional, is focused on driving real savings in the healthcare supply chain.

Globin Solutions

Series A in 2018
Globin Solutions, Inc. is a pre-clinical stage biopharmaceutical company that is committed to researching and developing a rapidly acting antidote for carbon monoxide poisoning, the most common human poisoning. Globin intends to aggressively develop its lead compound through preclinical testing with the goal to pursue regulatory clearance for clinical testing. Globin plans to partner with experts in globin chemistry and protein engineering through sponsored research agreements with the University of Pittsburgh to further develop their pipeline of agents for CO poisoning and other indications.

Xealth

Seed Round in 2017
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

ALung Technologies

Series C in 2017
ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.

Susquehanna Health

Acquisition in 2016
UPMC Susquehanna is an affiliate of UPMC and a northcentral Pennsylvania based health system that includes Divine Providence Hospital, Muncy Valley Hospital, Soldiers & Sailors Memorial Hospital and Williamsport Regional Medical Center. Serving patients from an 11-county region, UPMC Susquehanna has been recognized at the national and state levels for quality of care. This regional provider offers a wide array of services that include cancer care, heart and vascular care/heart surgery, neurosciences including neurosurgery, orthopedics, urology, OB/GYN, gastrointestinal services, behavioral health, physical rehabilitation, home care, long term care, assisted living and paramedic/ambulance services.

RxAnte

Funding Round in 2016
RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members while working with their prescribers and caregivers to make regimens safer, simpler, and more affordable.

Cernostics

Venture Round in 2016
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

medCPU

Venture Round in 2016
medCPU, Inc. delivers real-time clinical care advice through its Advisor Button technology for hospitals in the United States. Its Advisor Button captures the clinical picture from clinicians’ free-text notes, dictations, and structured documentation entered into EMR and analyzes it against a growing library of content for generating real-time precise prompts for care consideration; medCPU platform captures the clinical picture in real time, including narrative text and structured data to deliver the clinical and compliance guidance

Health Catalyst

Series E in 2016
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

Lantern

Series A in 2016
Finding emotional well-being during life’s twists and turns isn’t easy. Accessing care is at best expensive, and at worst completely out of reach. And that’s where Lantern comes in. Founded in 2012 in San Francisco, they’re a team of researchers, technologists, and clinicians translating clinical research and expertise into simple, effective web and mobile programs based in cognitive behavioral therapy. They’re not about unrealistic promises or get-happy-quick schemes. They’re about removing the stigma and barriers that prevent people from strengthening their emotional selves, offering a holistic approach to making every day better. They envision a world in which people think differently about their mental health–where they feel empowered to take a simple step toward self-improvement. They’re on a mission to make this happen, and they hope you’ll join us.

Health Fidelity

Venture Round in 2015
Health Fidelity simplifies risk adjustment, offering risk-bearing organizations clear visibility into and control over the process. Through our NLP-powered solutions and expert advisory services, we uncover insights that enable better care plans and more complete revenue capture. With the Lumanent™ suite, our partners have the confidence to pursue and ability to succeed in risk-sharing arrangements across MA, ACA, Medicaid, and ACO programs.

Prodigo Solutions

Venture Round in 2014
Prodigo Solution is a healthcare supply chain professional, is focused on driving real savings in the healthcare supply chain.

Evolent Health

Series B in 2013
Evolent Health is a population health management services organization. It integrates technology, tools, and on-the-ground resources to support health systems executing their population health and care transformation objectives.

dbMotion

Series C in 2009
The dbMotion™ Solution is a proven, connected healthcare, SOA-based interoperability platform that enables healthcare organizations and health information exchanges (HIEs) to meaningfully integrate and leverage their information assets, driving improvements in the quality, safety and efficiency of patient care. dbMotion transforms care through the creation of a virtual patient record that integrates patient information to connect care providers and settings.

dbMotion

Series B in 2005
The dbMotion™ Solution is a proven, connected healthcare, SOA-based interoperability platform that enables healthcare organizations and health information exchanges (HIEs) to meaningfully integrate and leverage their information assets, driving improvements in the quality, safety and efficiency of patient care. dbMotion transforms care through the creation of a virtual patient record that integrates patient information to connect care providers and settings.

BodyMedia

Series C in 2003
BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. Founded in 1999, the company today provides a variety of around-the-clock on-body monitors utilizing proprietary technology that has been clinically validated for accuracy. Data captured by BodyMedia devices is used by consumers as well as health and wellness professionals to guide behavioral changes to control weight and promote an active lifestyle – two factors that are routinely cited as keys to combat and manage serious medical conditions. BodyMedia has amassed one of the largest databases of information about the human body, and the technology has been used in more than 100 clinical research studies covering health issues such as obesity, COPD, diabetes, cystic fibrosis, cancer, bariatrics, sleep and intensive care. BodyMedia is privately held and based in Pittsburgh, PA. For more information, visit www.bodymedia.com.

Renal Solutions

Series A in 2002
Renal Solutions is focused on the development of dialysis products and services. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Renal Solutions was founded in 2000 and is based in Warrendale, Pennsylvania.

BodyMedia

Series B in 2002
BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. Founded in 1999, the company today provides a variety of around-the-clock on-body monitors utilizing proprietary technology that has been clinically validated for accuracy. Data captured by BodyMedia devices is used by consumers as well as health and wellness professionals to guide behavioral changes to control weight and promote an active lifestyle – two factors that are routinely cited as keys to combat and manage serious medical conditions. BodyMedia has amassed one of the largest databases of information about the human body, and the technology has been used in more than 100 clinical research studies covering health issues such as obesity, COPD, diabetes, cystic fibrosis, cancer, bariatrics, sleep and intensive care. BodyMedia is privately held and based in Pittsburgh, PA. For more information, visit www.bodymedia.com.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.